RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI – Get Free Report) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 88,500 shares, an increase of 88,400.0% from the December 31st total of 100 shares. Based on an average daily volume of 37,648,000 shares, the days-to-cover ratio […]
RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI – Get Free Report) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 88,500 shares, an increase of 88,400.0% from the December 31st total of 100 shares. Based on an average daily volume of 37,648,000 shares, the short-interest ratio […]
RespireRx Pharmaceuticals (OTCMKTS:RSPI – Get Free Report) is one of 960 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare RespireRx Pharmaceuticals to similar companies based on the strength of its profitability, dividends, risk, institutional ownership, earnings, valuation and analyst recommendations. Analyst Recommendations This […]
RespireRx Pharmaceuticals (OTCMKTS:RSPI – Get Free Report) is one of 960 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare RespireRx Pharmaceuticals to similar businesses based on the strength of its profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Volatility and Risk […]
RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI – Get Rating) saw a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 9,100 shares, a decline of 37.2% from the May 15th total of 14,500 shares. Based on an average daily trading volume, of 653,900 shares, the days-to-cover ratio […]